Therefore, FSTL1 overexpression may induce the differentiation of glioma cells into undifferentiated glioma stem-like cells, resulting in higher mortality and rapid disease progression in patients with glioma [29,30]. This evidence concerns the gene FSTL1 and central nervous system cancer.